Rapid Dose Therapeutics (XCNQ:DOSE) Debt-to-Revenue : 1.30 (As of Nov. 2024)

Rapid Dose Therapeutics Debt-to-Revenue Chart

Rapid Dose Therapeutics Annual Data
	Trend	Sep15	Sep16	Sep17	Sep18	Feb19	Feb20	Feb21	Feb22	Feb23	Feb24
Debt-to-Revenue		Get a 7-Day Free Trial					12.11	2.73	0.67	2.24	2.20

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Debt-to-Revenue	Get a 7-Day Free Trial															2.94	2.91	1.61	1.26	1.30

Competitive Comparison of Rapid Dose Therapeutics's Debt-to-Revenue

For the Biotechnology subindustry, Rapid Dose Therapeutics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Debt-to-Revenue falls into.

Rapid Dose Therapeutics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Rapid Dose Therapeutics's Debt-to-Revenue for the fiscal year that ended in Feb. 2024 is calculated as

Rapid Dose Therapeutics's annualized Debt-to-Revenue for the quarter that ended in Nov. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Nov. 2024) Revenue data.

Rapid Dose Therapeutics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description